Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity.
Cell Stem Cell
; 27(5): 813-821.e6, 2020 11 05.
Article
in En
| MEDLINE
| ID: mdl-32931730
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Induced Pluripotent Stem Cells
Limits:
Humans
Language:
En
Journal:
Cell Stem Cell
Year:
2020
Document type:
Article
Affiliation country:
United States
Country of publication:
United States